全文获取类型
收费全文 | 13468篇 |
免费 | 988篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 120篇 |
儿科学 | 231篇 |
妇产科学 | 184篇 |
基础医学 | 1851篇 |
口腔科学 | 407篇 |
临床医学 | 1348篇 |
内科学 | 3197篇 |
皮肤病学 | 202篇 |
神经病学 | 1193篇 |
特种医学 | 378篇 |
外科学 | 2062篇 |
综合类 | 124篇 |
一般理论 | 13篇 |
预防医学 | 1205篇 |
眼科学 | 251篇 |
药学 | 874篇 |
中国医学 | 12篇 |
肿瘤学 | 862篇 |
出版年
2023年 | 123篇 |
2022年 | 246篇 |
2021年 | 463篇 |
2020年 | 222篇 |
2019年 | 386篇 |
2018年 | 398篇 |
2017年 | 282篇 |
2016年 | 305篇 |
2015年 | 356篇 |
2014年 | 496篇 |
2013年 | 636篇 |
2012年 | 1010篇 |
2011年 | 985篇 |
2010年 | 555篇 |
2009年 | 519篇 |
2008年 | 839篇 |
2007年 | 893篇 |
2006年 | 852篇 |
2005年 | 904篇 |
2004年 | 831篇 |
2003年 | 706篇 |
2002年 | 646篇 |
2001年 | 130篇 |
2000年 | 98篇 |
1999年 | 115篇 |
1998年 | 153篇 |
1997年 | 113篇 |
1996年 | 97篇 |
1995年 | 95篇 |
1994年 | 69篇 |
1993年 | 69篇 |
1992年 | 53篇 |
1991年 | 41篇 |
1990年 | 48篇 |
1989年 | 47篇 |
1988年 | 49篇 |
1987年 | 54篇 |
1986年 | 55篇 |
1985年 | 42篇 |
1984年 | 52篇 |
1983年 | 47篇 |
1982年 | 52篇 |
1981年 | 30篇 |
1980年 | 30篇 |
1979年 | 31篇 |
1978年 | 14篇 |
1977年 | 26篇 |
1976年 | 23篇 |
1973年 | 14篇 |
1970年 | 16篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
Christophe Doddoli Adrian Aragon Fabrice Barlesi Bruno Chetaille Stéphane Robitail Roger Giudicelli Pierre Fuentes Pascal Thomas 《European journal of cardio-thoracic surgery》2005,27(4):680-685
OBJECTIVE: To assess the therapeutic effect of the extent of lymph node dissection performed in patients with a stage pI non-small-cell lung cancer (NSCLC). METHODS: We analysed data on 465 patients with stage I NSCLC who were treated with surgical resection and some form of lymph node sampling. The median number of lymph node sampled was 10 and the median number of ipsilateral mediastinal lymph node stations sampled was two. We chose to define a procedure that harvested 10 or more lymph nodes and sampled two or more ipsilateral mediastinal stations as a lymphadenectomy, by contrast with sampling when one or both criteria were not satisfied. The effect of the surgical techniques: lymph node sampling (LS; n=207) vs. lymphadenectomy (LA; n=258) on 30-day mortality and overall survival were investigated. RESULTS: A total of 6244 lymph nodes was examined, including 4306 mediastinal lymph nodes. The mean (+/-SD) numbers of removed lymph nodes were 7+/-6.1 per patient following LS vs.18.6+/-9.3 following LA (P=0.001). An average mean of 1+/-0.90 mediastinal lymph node station per patient was sampled following LS vs. 2.7+/-0.8 following LA (P<10(-6)). Overall 30-day mortality rates were 2.4 and 3.1%, respectively. LA was disclosed as a favourable prognosticator at multivariate analysis (Hazard Risk: 1.43; 95% Confidence Interval: 1.00-2.04; P=0.048), together with younger patient age, absence of blood vessels invasion, and smaller tumour size. CONCLUSIONS: Importance of lymph node dissection affects patients outcome, while it does not enhance the operative mortality. A minimum of 10 lymph nodes assessed, and two mediastinal stations sampled are suggested as possible pragmatic markers of the quality of lymphadenectomy. 相似文献
13.
14.
15.
16.
Joseph Cofrancesco Nina Shah Khalil G Ghanem Adrian S Dobs Robert S Klein Kenneth Mayer Paula Schuman David Vlahov Anne M Rompalo 《Gynecological endocrinology》2006,22(5):244-251
Drug use and HIV infection may affect sex hormone levels in women. One hundred and ninety-six women with and without a history of illicit drug use (50 HIV-negative and 148 HIV-infected), with regular menses, who never used antiretrovirals, were evaluated. Luteinizing hormone levels were significantly higher in women with a CD4 cell count <200/microl (p < 0.002). Current methadone use was associated with lower levels of total testosterone (p = 0.03) and higher levels of prolactin (p = 0.002); mean estradiol levels were 43% lower in women who used intravenous drugs (p < 0.001). Alcohol and crack cocaine use was not associated with sex hormone levels. Age, race, body mass index and degree of HIV immunosuppression were also associated with differences in sex hormone levels. 相似文献
17.
The purpose of this pilot single-site study was to assess efficacy and safety of levetiracetam for essential tremor, using a placebo-controlled, double-blind, randomized crossover design with an interim analysis planned after completion of the first 10 to 15 subjects. The study was designed to detect a mean 30% reduction in composite tremor score, comparable to that of primidone or propranolol, which can be demonstrated with 30 or fewer subjects. Each treatment arm included baseline tremor assessments, a 4-week medication titration, 2 weeks of stable dose, and treatment tremor assessments. Levetiracetam was titrated to 3,000 mg/day or to a lower maximal tolerated dose. The median age was 72 years, with 28 years median tremor duration. There was no statistically significant difference in response between placebo and levetiracetam on any tremor rating scale or accelerometry measure. The 95% confidence interval for the true mean difference between placebo and levetiracetam treatments was +18.5 to -22.5%, which excludes the minimum 30% drop required to consider levetiracetam clinically effective to a degree comparable to primidone or propranolol. Whether levetiracetam has lesser-degree antitremor efficacy was not addressed in this pilot study. 相似文献
18.
19.
Douglas M. Silverstein Ira Greifer Vaughn Folkert Boyce Bennett Howard E. Corey Adrian Spitzer 《Pediatric nephrology (Berlin, Germany)》1994,8(6):752-753
We report a patient who developed Henoch-Schönlein purpura (HSP) 13 years after he presented with IgA nephropathy (IgAN). In both HSP and IgAN renal biopsy most commonly reveals focal proliferative glomerulonephritis on light microscopy and immunofluorescence displays mesangial IgA deposits. In addition, patients with HSP or IgAN have elevated serum IgA levels, circulating IgA immune complexes, IgA-bearing lymphocytes, immunoglobulin-producing cells, and binding of IgG to glomerular components of similar molecular weight. The occurrence of both diseases in the same patient or the same families and the presence of immune abnormalities compatible with HSP or IgAN in relatives of patients with these diseases suggest a common pathogenesis. 相似文献
20.
Cholecystokinin (CCK) inhibits pancreatic cancer but not hepatic tumor induction by N-nitrosobis (2-oxopropyl) amine (BOP) in hamsters when administered with or shortly before BOP. In this study, we evaluated the capability of sulfated CCK-8 to inhibit DNA alkylation in the hamster pancreas. We examined the pattern of O6-methylguanine (G6-Me) and N7-methylguanine (G7-Me) in pancreatic ductal, acinar and liver tissues from Syrian hamsters treated with a single dose of BOP (20 mg/kg s.c.) and with five s.c. injections of CCK-8 (200 pM/kg, 30 min apart). The first CCK injection was given either 90 min before, or together, or 3 h after POP administration. The amount of G6-Me in liver DNA did not differ significantly. We observed a decrease of G7-Me in the liver of the group treated with CCK together with POP as compared to POP alone (P less than 0.005). Lower amounts of G6-Me were found in ductal preparations (P less than 0.01) of the animals treated with CCK before POP as compared to POP alone. CCK also modified the pattern of alkylation in the acinar tissue, but without a clear relationship with the timing of administration. The results suggest that the inhibitory effect of CCK-8 on pancreatic carcinogenicity of BOP could be related to its capability to modify DNA alkylation by yet unknown mechanisms. 相似文献